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Despite huge advances in the computational techniques
available for simulating biomolecules at the quantum-
mechanical, atomistic and coarse-grained levels, there is still
a widespread perception amongst the experimental commu-
nity that these calculations are highly specialist and are not
generally applicable by researchers outside the theoretical
community. In this article, the successes and limitations of
biomolecular simulation and the further developments that
are likely in the near future are discussed. A brief overview
is also provided of the experimental biophysical methods that
are commonly used to probe biomolecular structure and
dynamics, and the accuracy of the information that can be
obtained from each is compared with that from modelling. It
is concluded that progress towards an accurate spatial and
temporal model of biomacromolecules requires a combination
of all of these biophysical techniques, both experimental and
computational.
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1. Introduction
High-throughput sequencing, protein production and crystal-
lization, and developments in X-ray crystallography, small-
angle and wide-angle X-ray scattering (SAXS/WAXS),
electron microscopy (EM), mass spectrometry and nuclear
magnetic resonance (NMR), combined with modern data-
storage capacities, have enormously increased the quantity of
biological information available in structural, proteomics and
genomics databases. However, without an equivalent invest-
ment in understanding and interpretation in terms of biolo-
gical function, our ability to use this information is limited.
Computer modelling to enhance our understanding and guide
further experimental characterization is essential, since the
quantity and complexity of biological data is immense and
continues to grow.
Improved understanding of biomolecular interactions and
their consequences through computer modelling is not just of
fundamental interest, but is also of benefit to applied science.
Structural molecular biology has provided the key concepts
underlying rational drug design, which enables the use of
molecular design to target an active site or binding pocket of a
known structure. The desired outcome is usually a molecule
that specifically recognizes the correct binding site with suffi-
cient affinity to outcompete the natural substrate. However, it
is still not always possible to accurately predict the binding
constant simply from knowledge of the structures of the
individual binding partners because of a lack of a fully
quantitative understanding of the relationship between
molecular structure and thermodynamics. In spite of some
successes, it can also still be difficult to interpret calorimetric
data, for example gained by techniques such as isothermal
titration calorimetry (ITC), in terms of atomistic structure
alone, and this has proven troublesome to the pharmaceutical
industry, who would ideally use the insight provided by these
techniques to enhance drug development (Chaires, 2008).
A purely structural description has proven to be insufficient
for a complete understanding of biological function because
biomolecules are conformationally flexible objects. They
change shape significantly owing to thermal fluctuations when
they are at 300 K, and site-specific recognition can involve
large conformational changes as the biomolecules adapt their
flexible conformations to maximize favourable interactions.
In the case of allosteric interactions, these conformational
changes can give rise to information transfer through both
changes in shape and flexibility (e.g. entropy); dynamic
information transfer has, for example, been demonstrated
theoretically by Rodgers et al. (2013) and experimentally by
Tzeng & Kalodimos (2012). However, directly visualizing
these structural rearrangements and changes in biomolecular
flexibility remains challenging. Mesostable states can be
visualized by X-ray crystallography and gross structural rear-
rangements are observable by EM and SAXS/WAXS, but a
true time-resolved atomistic description
of the functionally related conforma-
tional rearrangements remains elusive
for most systems. NMR provides
detailed information on sample
dynamics, but remains limited by mole-
cule size and the need for isotopic
labelling. Spectroscopic methods [elec-
tron paramagnetic resonance (EPR),
Fo¨rster resonance energy transfer
(FRET) and optical and vibrational
spectroscopies] provide detailed infor-
mation on either very local structural
rearrangements or long-range distance
changes, but the challenge here lies in
linking this sparse information to a
complete description of the molecular
system (Fig. 1). In response to this,
biomolecular simulation has developed
algorithms which calculate the thermal
motion of biomolecules, in the hope that
this will offer a theoretical bridge
between thermodynamic measure-
ments, sparse distance information
and atomistic structure. Although
promising, these simulation methods
have not replaced experiments owing to
the approximations that are currently
needed for the calculations to be tract-
able. However, in common with
experiments, but unlike mathematical
modelling (for example using a ‘sphe-
rical cows’ approach; see Fig. 1), the
value of computer simulations improves
with improving technology.
In this article, we discuss the
successes and limitations of biomole-
cular simulations and the further
improvements that are likely in the near
future. We also provide a brief overview
of the experimental biophysical
methods commonly used to probe
biomolecular structure and dynamics
and compare the accuracy of the infor-
mation that can be obtained from each
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Figure 1
A comparison of the molecular-biophysics length scales and timescales accessible to simulation and
experiment. The term ‘spherical cows’ refers to approximate models that provide an abstract
representation of a physical system; such models are useful because of the simplicity of the
calculations (e.g. volumes or surface areas of a herd can be easily estimated by assuming that cows
are spherical and assigning a radius) and the general nature of the model (the volume of a goat herd
can easily be compared).
with that from simulation. We conclude that progress towards
an accurate spatial and temporal model of biomacromolecules
requires an integrated approach that uses a combination of all
of these biophysical techniques, both experimental and
theoretical (Zhao & Schuck, 2015).
2. The ‘resolution’ of biophysical methods and
comparison with simulation
In experimental biophysics, the term resolution refers to the
spatial and temporal dimensions accessible to a technique. In
addition, it should be noted that most biophysical experiments
are ensemble measurements that study the behaviour of a
population of macromolecules. Owing to the conformational
heterogeneity of macromolecules, this ensemble averaging
results in a loss of both spatial and temporal resolution.
The exceptions are single-molecule experiments. However,
although these are producing results about the physical
properties of macromolecules (atomic force microscopy),
reaction kinetics (single-enzyme kinetics) and subcellular
localization (super-resolution microscopy), they do not yet
provide atomic resolution information about the macro-
molecular structure.
We can broadly divide experimental biophysical techniques
into three classes. The first includes those techniques that are
able to provide both a high-resolution structural and poten-
tially temporal description of the entire macromolecule (i.e.
X-ray crystallography and EM). The second class comprises
techniques that provide sparse spatial information [i.e. EPR,
FRET, ITC, surface plasmon resonance (SPR), optical/vibra-
tional spectroscopy and single-molecule biophysics] that can
take the form of direct distance measurements, kinetics,
binding interaction data or very local spatial information.
These data, whilst sparse, can be of extremely high temporal
and spatial resolution. The third class includes those techni-
ques which can provide low-resolution structural information
on the entire macromolecule as well as information on
dynamics [SAXS/small-angle neutron scattering (SANS)/
WAXS, mass spectrometry, hydrogen/deuterium exchange
(HDX) and footprinting]. NMR is a special and extremely
versatile case as, depending on the exact experiment carried
out, it could be classified into any of the three classes. Indeed,
as long as an appropriate pulse sequence and sample-labelling
methodology can be devised, NMR can be used to probe the
structure and dynamics of the system of interest. A major
advantage of NMR is that the requirement for paramagnetic
nuclei for detection means that NMR can probe the structure
and dynamics of the molecule of interest in extremely complex
backgrounds such as crowded macromolecular environments
(Cabrita et al., 2010).
In spite of the wealth of biophysics techniques available,
in the main structural molecular biology has made progress
by using experimental design which simplifies highly complex
biological systems. For example, binding-affinity measure-
ments and ITC are performed in dilute solution under
conditions where only the binding partners of interest are
included, under the assumption that the cellular environment
is not significant. However, fundamental processes such as
protein folding, which are commonly studied in isolation, are
known to be influenced by the presence of the ribosome and/
or chaperones. X-ray crystallography requires a homogeneous
crystalline environment which may more closely reflect the
crowded environment of the cell, but does not reflect its
heterogeneity. Indeed, the effects of crowding are clearly
important for in vivo protein function (Ellis, 2001).
Model building and approximation are already endemic in
the biosciences, as it has been necessary to take a reductionist
approach when designing experiments to overcome the
complexity inherent in molecular biology; consequently,
nearly all in vitro experiments are an abstraction of the real
in vivo system. Computer simulations provide a different, but
no less valid, and often more detailed, technique for model
building. Currently, most simulations begin from data
provided by experimentalists and this places a large respon-
sibility on both the experimenter and theoretician to under-
stand the capabilities, limitations and assumptions of each, as
has been previously discussed (Coveney & Fowler, 2005).
3. Computer simulations of biomolecules
Computer simulations of biomolecules aim to integrate high-
accuracy physical models with efficient parallel computer
algorithms running on the best available supercomputing
hardware, which often requires infrastructure at the national
level, such as the UK supercomputer ARCHER (hardware
will be discussed in x4). Simulation algorithms are continu-
ously updated to exploit advances in computing architectures,
such as graphics processing units (GPUs), and atomistic
molecular-dynamics (MD) simulations have been considered
to be sufficiently useful to society that Shaw Research have
designed a special-purpose parallel architecture for fast MD,
known as Anton, which has been reported to run simulations
two orders of magnitude faster than conventional resources
(Dror et al., 2012). Since a more accurate physical description
nearly always entails higher computational expense, including
fewer spatial details usually allows longer timescales and
length scales to be explored. Molecular models at the quantum
and atomistic levels require that the atomistic structure of the
biomolecule is known. Either the experimental coordinates
are downloaded from the Protein Data Bank (PDB), or the
structure has to be predicted by homology modelling. Recent
developments in high-resolution cryo-EM promise to provide
a new source of high-resolution structural data (Brown et al.,
2015; Lucˇicˇ et al., 2013). Coarse-grained simulation methods
do not necessarily suffer from this restriction, and can take
advantage of the growing Electron Microscopy Data Bank
(EMDB). The aim is then to use computation to calculate
quantities that are unobtainable from experiments alone, such
as the magnitude of conformational changes owing to thermal
motion. While robust validation is always required when
predictions go beyond what is experimentally accessible, the
range of applicability of the models is usually well known and
the limitations understood. The precise validation required
and the nature of these limitations will be specific to the
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biological question being addressed, and requires careful
thought on behalf of the simulator. An example, however,
would be good agreement between the time-averaged struc-
ture of a protein calculated from an MD simulation and the
X-ray structure used as input to the simulations (Rueda et al.,
2007).
The following section aims to provide a flavour of the
wealth of computational studies that have been performed for
biomolecules at each particular level of accuracy using specific
examples, but is by no means intended to be exhaustive.
Consequently, we refer the curious reader to the many reviews
cited for a more detailed account of a particular biomolecular
simulation technique. We also encourage researchers who
wish to perform their own simulations to engage with the
comprehensive series of tutorials and workshops provided
by the websites of biomolecular simulation software codes
such as GROMACS (http://www.gromacs.org/Documentation/
Tutorials) or AMBER (http://ambermd.org/tutorials/), and
invite them to attend the practical workshops run by CCP5
(http://www.ccp5.ac.uk/events/) and by CCP-BioSim (http://
www.ccpbiosim.ac.uk/workshops).
3.1. Quantum-mechanical calculations
Whilst reactions involving the reconfiguration of covalent
bonds are ubiquitous in biochemistry, representing the distri-
bution of electrons within biomolecules is extremely compu-
tationally expensive. Nevertheless, quantum-mechanical (QM)
calculations have been used, for example, to understand the
catalytic ability of enzymes, to predict how key mutations may
affect catalytic efficiency and to explain the high selectivity of
enzyme-catalysed reactions. They have been used to reveal the
structures of short-lived species such as transition states, which
can then be used as templates for the design of enzyme inhi-
bitors for biotechnological or medicinal applications (Lons-
dale et al., 2012a).
A typical quantum-chemical calculation solves the Schro¨-
dinger equation to determine the energy and electronic
configuration of the valence electrons associated with a
particular set of coordinates for the atomic centres. Deter-
mining the electronic structure shows to what extent a given
pair of atoms are covalently bonded, where the electrons are
distributed and where the biomolecule is polar or apolar, and
can provide the empirical parameters required for classical
atomistic simulations. When applied to enzyme catalysis, QM
calculations have been used to understand how the enzyme
lowers the activation-energy barrier of the chemical reaction
by perturbing the electronic structure of the transition state.
Short-lived species such as transition states are hard to isolate
experimentally, hence calculations are used to provide infor-
mation that would otherwise be inaccessible. In complex
biochemical reactions, the detailed mechanism of the
catalysed reaction may not be well understood, and in this
situation quantum-chemical calculations can test and compare
hypotheses in silico. When combined with geometry-
optimization algorithms, which adjust the relative positions of
the atomic nuclei in conjunction with the molecular orbitals,
quantum-chemistry calculations can show how the shape and
electronic structure of biomolecular fragments change along a
reaction pathway on the sub-a˚ngstro¨m length scale. Many
QM methods are too computationally intensive to permit
molecular-dynamics (MD) simulations and instead are used
to calculate potential energy profiles, from which one may
deduce the pathway taken during a chemical reaction by
calculating the lowest energy route across a potential energy
landscape. Relative reaction rates, for example when residues
in an enzyme active site are mutated, can then be predicted
by comparing the heights of the energy barriers between the
reactants and products. Reaction rates can also be compared
between different substrates. Also, by comparing the relative
energy barriers to different proposed mechanisms, the most
likely mechanism can be deduced (i.e. that with the lowest
barrier).
The bottlenecks in quantum-chemical calculations are
usually the matrix-diagonalization operations to obtain the
wavefunctions of the molecular orbitals occupied by the
valence electrons in the molecule, which are both slow and
memory intensive. The so-called post-Hartree–Fock ab initio
methods are the most accurate QM methods, and examples of
these include Møller–Plesset perturbation theory (MP2) and
coupled-cluster theory. These methods can be used to study
model reactions that involve a relatively small number of
atoms (20) to a high degree of accuracy, e.g. for gas-phase
bimolecular reactions or for small cluster models of enzyme
active sites. For reactions involving significantly more atoms,
e.g. for enzymatic reactions with multiple residues partici-
pating in the mechanism, these methods are usually not
feasible for routine application. The cheapest QM methods
are the semi-empirical methods (e.g. AM1 and PM3), the
name arising from the fact that the more expensive parts of the
QM calculation are approximated by a set of parameterized
functions that are based on empirical data. These are used for
calculations requiring a large number of QM atoms (100
atoms) and for calculating free-energy barriers. However,
semi-empirical methods have limited applicability because
they are parameterized for a finite set of reactions and are not
derived from first principles. Whilst they have been shown to
provide useful insight for reactions that are similar to those
that they have been parameterized for, their accuracy is less
good for reactions which deviate too far from the para-
meterization set. Density-functional theory (DFT), which is
intermediate in complexity between semi-empirical and ab
initiomethods, provides a good compromise between accuracy
and computational cost. However, DFT calculations generally
do not include dispersion (e.g. van der Waals) interactions, so
for biological molecules in which such forces play an impor-
tant role in stabilizing folded conformations these need to be
added empirically (Lonsdale et al., 2010, 2012b). There are
various types of density functional which differ in the way in
which electron exchange and correlation is mathematically
represented. One of the most popular functionals is B3LYP,
which has been used successfully to calculate molecular
geometries and energies reasonably accurately compared with
more computationally intensive methods. It is known as a
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hybrid functional, because the electron exchange is calculated
using a linear combination of three different methods, and
their relative contributions have been parameterized to fit to
experimental data.
For large biomolecules where the active site forms a small
section of the entire protein, hybrid quantum-mechanical/
molecular-mechanical (QM/MM) methods are used (van der
Kamp & Mulholland, 2013). QM/MM calculations use clas-
sical molecular mechanics (MM) to represent the atoms that
do not take part in the chemical reaction, but treat the active-
site quantum mechanically. The classically treated atoms
within the model affect the energies of the chemically reacting
species firstly through the presence of the MM region placing
a restriction on the movement of the QM region during
minimization, i.e. the MM atoms hold the QM region in
position, and secondly through long-range electrostatic inter-
actions, although only the more accurate QM/MM methods
allow the MM region to polarize the QM region. In addition,
the protein as a whole may routinely undergo large confor-
mational changes during its thermal motion, so an ensemble of
structures (at least five) is considered in state-of-the-art QM/
MM models to ensure that the changing shape of the active
site is included in the potential energy surface calculations.
This ensemble of structures is usually obtained from an MD
simulation of the enzyme–substrate complex (MD simulations
are discussed in more detail in x3.2).
Knowledge of the factors that determine the reactivity and
selectivity of drug metabolism is useful in the design of new
pharmaceutical compounds that do not result in the formation
of toxic metabolites (Lonsdale & Mulholland, 2014). An
example application of QM/MM methods for studying drug
metabolism focused on the regioselectivity of hydroxylation of
drug molecules by the human cytochrome P450 2C9 enzyme.
The QM region was modelled using the B3LYP density
functional (with an empirical dispersion correction), and the
rest of the enzyme and the solvent were represented using the
CHARMM27 force field, as shown in Fig. 2 and Supplemen-
tary Movies S1 and S2 (Lonsdale et al., 2013). The calculations
showed that relatively small changes in substrate orientation
relative to active-site residues can have a dramatic effect on
the heights of relevant energy barriers. The reactive species
in P450s is a highly reactive iron(IV)–oxo species (called
Compound I) which is difficult to isolate experimentally and
has a complex electronic structure (Bathelt et al., 2005).
Calculating the energy barriers to the reaction at different
sites of the reacting molecules found that the lowest barriers in
two out of three cases corresponded to the oxidation sites
observed experimentally, which provided good evidence that
QM/MM calculations can be used to reliably predict the site of
metabolism for drugs in P450 enzymes. These calculations also
revealed that the mechanism underlying the selectivity of P450
enzymes is a combination of factors involving the orientation
of the substrate in the active site and the differing reactivities
of chemical sites on the substrate. In common with many
enzymes, the human cytochromes P450 are membrane-bound;
however, all known crystal structures to date have been
obtained for solubilized forms in the absence of membrane.
In a recent study, a membrane-bound model of the human
CYP3A4 isoform was constructed using a combination of
atomistic and coarse-grained molecular-dynamics simulations
(Lonsdale et al., 2014). QM/MM (B3LYP-D/CHARMM27)
reaction profiles were calculated both from membrane-bound
and soluble forms of the enzyme. The calculations revealed
that the reactivity of the enzyme is similar between the two
forms; however, important differences were observed between
the substrate entrance and exit pathways. It is hoped that the
framework outlined in this study can be applied to the study of
other membrane-bound enzymes.
In principle, QM/MM methods should be applicable to all
enzymes, yet whilst many enzymes have been studied using
such methods (van der Kamp & Mulholland, 2013; Ranaghan
& Mulholland, 2009), these calculations are not yet routine.
The choice of an appropriate QM method depends on the
system and the type of problem to be addressed. Also, the size
of the QM region and other practical aspects are important
and should be thoroughly tested for each new application
(Lonsdale et al., 2012a). The classical MM region is treated
using invariant point charges and (unless a polarizable MM
model is used) cannot be polarized by changes in charge on
the QM atoms. This can be overcome by increasing the size of
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Figure 2
The transition state for the hydroxylation of S-ibuprofen at C3 in the
human drug-metabolizing cytochrome P450 2C9 (Lonsdale et al., 2013).
The H atom at C3 undergoes abstraction by the ferryl O atom of the
porphyrin (shown as a yellow dashed line). Knowledge of the mechanism
and transition states for reactions such as these can be useful in the design
of new pharmaceutical compounds with desired metabolic properties.
The reaction was modelled with QM/MM (using the QoMMMa program;
Harvey, 2004) using multiple starting structures taken from MD
simulations (performed using CHARMM; Brooks et al., 1983) and the
CHARMM27 force field (MacKerell et al., 2000). The QM region is
shown in ball-and-stick representation.
the QM region to incorporate more of the surrounding atoms,
but this increases the computational expense. Conformational
sampling is also an important issue, and reaction profiles
should be calculated starting from different conformations of
the enzyme (i.e. using different structures from an MD simu-
lation), which additionally increases the computational cost
because it requires each calculation to be performed multiple
times.
3.2. Classical atomistic molecular dynamics (MD)
Atomistic molecular-dynamics (MD) simulations have
famously been described as providing a ‘computational
microscope for molecular biology’ (Dror et al., 2012) because
simulations viewed on a computer screen can create the
impression that the biomolecule has been magnified to suffi-
cient dimensions that it is being visualized with optical
microscopy. MD provides a trajectory of a biomolecule which
shows how it changes shape as it undergoes thermal fluctua-
tions at 300 K, as shown in Supplementary Movie S3. The MD
algorithm treats every atom within the protein as a classical
ball connected by covalent bonds, which are represented as
perfect harmonic springs and which therefore cannot break.
Nonbonded atom pairs interact through van der Waals (or
dispersion) interactions and electrostatics. Each atom in the
system is assigned a set of empirical parameters designed to
impart chemical specificity, which are known as the MD force-
field parameters. For example, each atom carries a partial
charge depending upon its electronic properties and its
environment. MD force-field parameters are derived from a
combination of experimental data (such as vibrational spec-
troscopy of small molecules) and QM calculations on tractable
molecular fragments, and are constantly being iteratively
debated, checked and improved. The solvent environment
is generally also represented at the atomistic level. Conse-
quently, calculations involving proteins in membranes are
more computationally expensive owing to the need to simulate
the lipid bilayer. The change in position of every atom in
response to the force that it experiences from all of the others
is calculated over a very short numerical integration timestep
(typically 2 fs) using Newtonian mechanics. The bottleneck in
MD arises from the enormous computational expense of
calculating the net force on every particle from all other
particles in the system at each short timestep interval.
However, if the timestep is too long then the energy will
progressively inflate and the simulation will become numeri-
cally unstable. Consequently, even with parallel computing,
MD simulations exploring timescales of tens of microseconds
are currently considered to be state of the art, although
timescales of milliseconds have been achieved using specia-
lized resources (Shaw et al., 2010).
Atomistic molecular-dynamics simulation is arguably the
most mature biomolecular modelling technique. Recent
research highlights from this field include the MoDEL simu-
lation database, which provides the biomolecular sciences
community with a database containing in excess of 1700
protein trajectories obtained by state-of-the-art MD simula-
tions which can be freely downloaded (Meyer et al., 2010),
insights into protein-folding mechanisms for fast folders
(Lindorff-Larsen et al., 2011), atomistic information on the
structure and dynamics of 100 nm cages constructed from self-
assembling coiled-coil peptides to complement scanning
electron-microscopy data (Fletcher et al., 2013) and simula-
tions of the entire tubular HIV-1 capsid assembly based on
cryo-electron tomography (Zhao et al., 2013). There is an
established software infrastructure used by a global simulation
community, such as the MD codes NAMD (Phillips et al.,
2005), GROMACS (Pronk et al., 2013), CHARMM (Brooks et
al., 1983) and AMBER (Case et al., 2014), and accompanying
visualization tools such as VMD (Humphrey et al., 1996),
Chimera (Pettersen et al., 2004) and PyMOL (Schro¨dinger).
MD computer programs have been optimized for parallel
performance on national resources and new architectures such
as GPUs, and are generally free to academics. While a user can
chose between AMBER or CHARMM force-field parameters,
many simulators routinely compare the results from several
force fields as there are no set rules for choosing one over the
other, although the differences are usually small (Rueda et al.,
2007). Multiple replicate simulations (typically at least three,
but more than ten are now common) are also required because
thermal effects can be so significant at 300 K that a chance
event observed in a simulation can be mistaken for an
important mechanistic result.
While the Nobel Prize for Chemistry in 2013 was awarded
for the development of multiscale models of complex chemical
systems, and in spite of the fact that the first successful
biomolecular simulation was reported in 1977 (McCammon et
al., 1977), it is disappointing that we are still unable to routi-
nely provide an accurate prediction of biomolecular affinities
(which are governed by the change in free energy when
biomolecules associate) using atomistic simulation, even for
small molecules. However, the physical attributes that allow
proteins to perform such extraordinary functions in vivo also
make their interactions very challenging to describe quanti-
tatively. Many proteins act as switches or participate in
signalling cascades. Therefore, biomolecular affinities are
often modulated through allosteric interactions with other
molecules or by environmental perturbations, such as changes
in pH, temperature or salt concentration. To be switchable,
free-energy differences must be delicately balanced, which
implies that they are modest in magnitude compared with the
thermal energy. This is achieved thermodynamically firstly
because all biomolecular interactions are mediated by the
solvent; binding partners need to displace a layer of bound
solvent before the interaction can proceed. Assuming that
these solvent interactions can be overcome, the remaining
favourable interaction energy that drives molecular associa-
tion is generally (but not always) offset by unfavourable
changes in entropy, which occur because the conformational
flexibility of any molecule tightly bound within a complex is
usually reduced relative to its unbound state. Consequently,
the overall free-energy change that drives molecular recog-
nition involves a number of large but compensating terms that
are opposite in sign, with the result that even a small error in
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the calculation of any one component leads to a large error in
the overall value predicted by theory.
The importance of dynamics and entropy in biomolecular
function is particular challenging for computation, because
calculation of the entropy requires a full exploration of the
conformational space of the biomolecule. In response to this,
the community has developed a plethora of innovative
computational and algorithmic techniques designed to provide
a more efficient exploration of conformational space (Zuck-
erman, 2011). Examples include replica exchange, which uses
elevated temperatures to force the biomolecule to move more
rapidly across its free-energy landscape, and metadynamics
or conformational flooding, which impose restraints upon a
biomolecule that place a bias against revisiting areas of
conformational space that the simulator has already observed,
as described by Zuckerman (2011). While much progress has
been made using these techniques, especially in the area of
drug design (see part VI of Baron, 2012), they are certainly not
routine. More sophisticated algorithms often provide results
that are more difficult to interpret, and care must be taken that
any additional artefacts that are introduced are not hidden
behind this extra layer of complexity.
3.3. Coarse-grained biomolecular simulation
Atomistic molecular-dynamics simulations are computa-
tionally very demanding; each atom is considered to be a
single particle, which results in many interaction sites. The
greater the number of interaction sites, the slower the simu-
lation. These simulations can become prohibitively slow for
studying processes such as the self-assembly of lipid bilayers
and protein-oligomerization events. An alternative approach
is to use coarse-grained models (for a recent review, see
Tozzini, 2010). In such models, a group of heavy (non-H)
atoms are combined together into a single, larger particle,
thereby reducing the number of interaction sites. A coarse-
grained simulation can thus access longer timescales and
length scales than is possible by atomistic simulations, albeit at
the cost of the atomistic detail. The speed-up in the sampling
of phase space achieved by CG force fields for biomolecular
simulation can vary between five and ten times faster (Marrink
et al., 2004) to 15–200 times faster (Orsi & Essex, 2011). The
simulation speed-up is a result of the reduced system size, but
also the ‘softer’ potentials used to describe the interactions
within the particles, which result in smoother energy land-
scapes compared with atomistic simulations and enable longer
integration timesteps to be used. While many coarse-grained
models have been reported and are widely used within the
wider biomolecular simulation community, arguably the most
popular is currently the MARTINI force field (Marrink et al.,
2004; Marrink & Tieleman, 2013). In general, four heavy
atoms are lumped together into a single particle in MARTINI,
which gives rise to the representation of water shown in
Fig. 3(a). MARTINI is usually implemented within the
GROMACS simulation package; for
examples, see Bond et al. (2007) and
Scott et al. (2008).
An example of the use of coarse-
grained biomolecular simulation to
study systems that would be computa-
tionally inaccessible to atomistic calcu-
lations is provided by Supplementary
Movie S4, which shows the self-
assembly of lipids around an outer
membrane protein (Bond & Sansom,
2006). Supplementary Movie S5 and
Fig. 3(b) show a recent study of the
membrane protein fukutin (Marius et
al., 2012; the lipid membrane has been
omitted for clarity). Fukutin resides in
the endoplasmic reticulum or the Golgi
apparatus within the cell. Its localization
is thought to be mediated by the inter-
action of its N-terminal transmembrane
domain with the surrounding mem-
branes. Experimental work has shown
that this domain exists as a dimer within
the lipid bilayers; however, the process
of dimerization, the structure of the
dimers and the localization within the
membranes are difficult to probe using
experimental methods alone. Coarse-
grained MD simulations predict steps in
the dimerization process, in which a
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Figure 3
Coarse-grained biomolecular simulations. (a) A schematic of the water model in which four
atomistic water molecules are lumped together in a single particle (indicated by the grey sphere).
(b) Initial (left) and final (right) positions observed during the dimerization of fukutin. The protein
backbones are shown in cyan, the S residues of the important TXXSS motif are shown in orange
space-filling format, the phosphate groups of the lipids are shown in purple space-filling format, and
the remainder of the lipid molecules and the waters have been omitted for clarity.
TXXSS motif is crucial in holding the dimer together. Fig. 3(b)
(left) shows the initial positions of the N-terminal trans-
membrane domains of two fukutin proteins compared with
their dimerized state after 2 ms of coarse-grained MD simu-
lation (Fig. 3b, right).
Much of biomolecular simulation has been inspired by the
wealth of structures available in the PDB, and has therefore
been focused on providing theoretical methods that use this
information as direct input to computations. However,
progress in lower resolution methods, such as cryo-electron
microscopy and cryo-tomography, is leading to a rapid growth
in the number of structures available in the EMDB. In
response, biomolecular simulators have designed simulation
techniques that take advantage of these new experimental
data (Kim et al., 2011). While the PDB provides atomistic
structures, the EMDB provides lower resolution volumetric
information illustrating the overall shape of biomolecules,
biomolecular complexes or supermolecular structures.
Therefore, one strategy for simulating EMDB maps is to use a
continuum representation in which no atoms or particles are
present at all. Such an approach is common at the macroscopic
level. Finite-element analysis (FEA) is used ubiquitously for
computer-aided design within structural engineering applica-
tions, but does not take thermal noise into account.
Fluctuating finite-element analysis (FFEA) is a general-
ization of FEA to objects which are sufficiently small that
thermal fluctuations are non-negligible in magnitude (Oliver
et al., 2013). In FFEA, the complex shape of the protein is
represented by a three-dimensional mesh of elements, with
the most convenient element shape being the tetrahedron, as
shown for the rotary ATPase motor in Fig. 4. This mesh is then
parameterized with continuum material parameters such as
the density of the protein, its Young’s modulus and the visc-
osities of the biomacromolecule and its solvent environment.
These material parameters should describe the cumulative
effect at the continuum level of all of the local atomic inter-
actions. Once these parameters have been defined, the
trajectory describing the changing shape of the protein owing
to thermal fluctuations can be calculated by iteratively inte-
grating Newton’s equations of motion over short timesteps
and moving each node of the mesh accordingly, as shown
for the rotary ATPase motor in Supplementary Movie S6
(Richardson et al., 2014). The calculation is analogous to
conventional molecular dynamics (MD), but the forces on
each node within the mesh are derived from continuum
mechanics equations rather than a pairwise particle-based
force field. Since it operates in the continuum limit it has no
upper length scale, and it is sufficiently coarse-grained to
enable simulations of very large protein structures to be
performed for long (e.g. microsecond) timescales. As long as
the necessary force-field parameters can be obtained, FFEA
can include intermolecular forces between biomolecules (such
as van der Waals and electrostatics interactions) and it is also
possible to simulate collections of interacting proteins, protein
association and disassociation or proteins immersed in
complex subcellular environments.
An alternative approach for studying very large proteins
and protein complexes improves computational efficiency
by simplifying the mathematical equations rather than the
biomolecules themselves. Gaussian and elastic network
models (ENMs) are a widely used class of structure-based
coarse-grained models for proteins which represent the native
structure of the protein as an elastic body comprised of a set of
nodes connected by springs (Noid, 2013). Using simple springs
to represent all of the intermolecular interactions within the
protein enables the equations of motion to be solved exactly
by a procedure known as normal-mode analysis, without the
need to run a simulation or obtain a dynamical trajectory. The
calculation provides a set of structural
deformations known as the ‘normal
modes’ that represent the major modes
of flexibility of the biomolecule and
which have been shown to correspond
to protein global motions observed over
microsecond or millisecond timescales
by atomistic simulation (Gur et al.,
2013). Given the approximations
required to produce such a simplified
potential function, ENM and GNM
frequently also use a coarse-grained
protein representation in which a single
bead represents each C atom, and
continuummethods based on FEA have
also been employed (Bathe, 2008). The
value of these models lies in their
simplicity: to calculate the normal
modes of a protein of interest a user
simply needs to upload the PDB file (for
example to the elNe´mo webserver;
Suhre & Sanejouand, 2004) and down-
load the results.
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Figure 4
From left to right, this figure shows the EMDB density map of the Thermus thermophilus
A-ATPase, the corresponding FFEA mesh and the ‘solid’ version of this mesh (Richardson et al.,
2014).
4. Computing infrastructure in 2014 in the UK and
beyond
Just as optical microscopy faces physical limitations on the size
and the resolution of the observations that it can make, the
‘computational microscope’ of biomolecular simulation is not
infinitely powerful, as even the most sophisticated super-
computers cannot provide unlimited computational power.
Indeed, in spite of rapid technological and algorithmic
improvements, it is unlikely that supply will meet demand
in the near future. However, while the most ambitious bio-
molecular simulations make use of high-end computing, many
simulations only require modest resources. The provision of
computing in the UK and elsewhere, the so-called ‘e-infra-
structure’, can be represented as a pyramid, as shown in Fig. 5.
Examples of provision at each of these levels, of how to obtain
access and example suitable calculations have been provided
in Table 1.
ARCHER (Academic Research Computing High End
Resource; http://www.archer.ac.uk) is the current UK National
High Performance Computing Facility, physically located in
Edinburgh and operated by EPCC, The University of Edin-
burgh. The funding for ARCHER is provided through the
UK Research Councils, managed by EPSRC. At the time of
writing, ARCHER, a CRAY XC30 comprising 3008 nodes,
is rated 19 on the list of the worlds’ fastest supercomputers
(http://www.top500.org). Such large-scale computers are
required to perform leading-edge scientific and engineering
simulations that are not feasible on smaller-scale computers.
Each ARCHER node can be thought of as analogous to a
high-end consumer PC, since it contains commodity processor
and memory chips. Each node contains two 12-core Intel
Ivy-Bridge processors and 64 GB of memory (with a few
nodes featuring larger amounts of memory). Therefore,
ARCHER features 72 192 cores and approximately 200 TB of
memory in total.
The ARCHER infrastructure is specialized in order to
effectively combine multiple processor and memory compo-
nents into a high-performing large-scale system. The nodes
are very densely packed onto compute blades, which slot into
cabinets. The servers, plus additional infrastructure (the
ARCHER switch room is shown in Supplementary Fig. S1,
bottom right), provide the necessary power to the nodes,
whilst performing the required cooling through the use of
flowing water, as shown in Supplementary Fig. S1 (bottom
left). For the nodes to effectively work together on single
large-scale problems, they must be able to communicate with
each other, and this is facilitated through the availability of the
state-of-the-art CRAY Aries high-performance interconnect,
as shown in Supplementary Fig. S1 (top right). Large-scale
applications also typically require manipulation of large data
sets, and ARCHER provides a Lustre parallel file system that
allows the efficient reading and writing of application data.
ARCHER is co-located with and closely coupled to the
Research Data Facility (http://www.epcc.ed.ac.uk/facilities/
uk-research-data-facility), which provides a large long-term
data-storage area for UK researchers. ARCHER provides
a sophisticated and comprehensive software environment,
including pre-installed applications and development tools,
to help enable researchers to get the best out of the service.
Finally, ARCHER also offers support services, ranging from a
helpdesk facility to long-term scientific software development
programmes. The High End Consortium (HEC) for Bio-
molecular Simulation (http://www.hecbiosim.ac.uk) will be
providing both supercomputer time and expertise to the
community until Autumn 2018. Other routes of access include
the EPSRC; supercomputing time can be included on BBSRC
responsive mode grants.
For calculations that do not require the full capacity offered
by ARCHER, but which nevertheless require specialist
supercomputing resources, the UK e-intrastructure provides
a number of regional supercomputing centres. The Hartree
Centre was opened in February 2013 at the STFC Daresbury
Laboratory. There is a particular focus on delivering solutions
to industry, but academic/industrial collaborations and infra-
structure projects are also supported. Other regional facilities
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Figure 5
The UK e-infrastructure pyramid.
Table 1
UK supercomputing provision, modes of access and typical suitable calculations for each tier.
Access QM MD
ARCHER http://www.hecbiosim.ac.uk 250 cores, DFT of enzyme with 2500
atoms (10 kDa). One geometry
optimization requires 200 h
512 cores, MD of 256 bp DNA circle in water
(150 kDa), 4 million atoms, up to 50 ns
N8 http://www.n8hpc.org.uk As for ARCHER 64 cores, MD of 100 bp DNA circle in water
(50 kDa), 500 000 atoms, up to 100 ns
Hartree hartree@stfc.ac.uk
EMERALD (GPU) and Iridis support@einfrastructuresouth.ac.uk
Local N/A High-level QM is normally memory-
limited so it is advantageous to
own a few local large nodes
16 processors, MD of 20 bp DNA in water
(10 kDa), 35 000 atoms, up to 1 ms
include the N8 supercomputer, Polaris (shown in Supple-
mentary Fig. S1, top left), which is openly available to any
researcher at an N8 university (the N8 is a collaborative
structure between eight of the northern UK universities), and
in the south the Centre for Innovation provides access to
conventional HPC computing (IRIDIS) and the EMERALD
GPU cluster. Pioneering biomolecular simulators have
invested in local GPU clusters, which are generally compar-
able in price to a multiprocessor workstation, but which at the
time of writing can run an MD calculation four times faster
than a typical 16-processor workstation using the AMBER12
software package. While some established codes (such as
AMBER; Le Grand et al., 2013) already have specialized
versions that run on GPU technology, much useful software
has not yet been adapted and so will not run, or will run only
with reduced functionality. Using multiple GPUs for a single
calculation may provide only a modest (20%) speed-up (the
speed-up is very dependent on application and system size);
however, the use of a facility such as EMERALD enables
many replica simulations to be run, which massively improves
conformational sampling (Woods et al., 2013).
Most useful day-to-day molecular modelling, however, is
achieved with conventional, smaller-scale local resources.
For example, an eight-processor workstation is capable of
performing around 10 ns of modelling a day usingGROMACS
for a solvated protein such as ubiquitin, which contains around
70 residues. This is sufficient, for example, to check the
stability of a recently solved biomolecular X-ray or NMR
structure, which can provide a basic ‘sanity check’ before the
atomic coordinates are deposited. With such a simulation it is
possible to identify particularly flexible residues within the
protein or to obtain a quick assessment of the stability of a
binding pose of a docked ligand. The persistence of key
intramolecular or intermolecular contacts can be investigated
at room temperature and in the absence of crystal-packing
contacts. It can also be used to investigate the possibility that
technical details of the experimental procedure, such as the
inclusion of His tags for purification or buffer conditions
(Majorek et al., 2014), might possibly influence the outcome of
the experiment. Most importantly, molecular modelling and
simulation gives researchers the opportunity to visualize their
system of interest, which can rapidly change perceptions in
surprising and invaluable ways.
5. Future perspectives
Simulations have comparable advantages and caveats to the
other experimental techniques presented, and should not be
regarded as any less valid so long as they are used appro-
priately and the corresponding limitations are clearly stated.
To conclude, we argue that the biomolecular sciences need to
embrace computer simulation as a useful technique for model
building and hypothesis testing, especially given the vast
quantities of biomolecular data that are being generated. Most
insight will be obtained by combining all available biophysical
methods to address a single biological problem, and computer
simulation can make a valid and valuable contribution. We
note that the original longer title for this paper ‘A Perspective
on Computer Simulation as a Biophysical Technique’ was
shortened at the insistence of an anonymous referee, who
stated ‘there are insufficient data in the paper to substantiate
the connotation of simulation as a biophysical technique’. We
leave it to the reader to form their own opinion.
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thank EPSRC for support (grant numbers EP/J010588/1 and
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References
Baron, R. (2012). Editor. Computational Drug Discovery and Design.
Totowa: Humana Press.
Bathe, M. (2008). Proteins, 70, 1595–1609.
Bathelt, C. M., Zurek, J., Mulholland, A. J. & Harvey, J. N. (2005). J.
Am. Chem. Soc. 127, 12900–12908.
Bond, P. J., Holyoake, J., Ivetac, A., Khalid, S. & Sansom, M. S. P.
(2007). J. Struct. Biol. 157, 593–605.
Bond, P. J. & Sansom, M. S. P. (2006). J. Am. Chem. Soc. 128, 2697–
2704.
Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J.,
Swaminathan, S. & Karplus, M. (1983). J. Comput. Chem. 4,
187–217.
Brown, A., Long, F., Nicholls, R. A., Toots, J., Emsley, P. &
Murshudov, G. N. (2015). Acta Cryst. D71, 136–153.
Cabrita, L. D., Dobson, C. M. & Christodoulou, J. (2010). Curr. Opin.
Struct. Biol. 20, 33–45.
Case, D. A. et al. (2014). AMBER14. University of California, San
Francisco, USA.
Chaires, J. B. (2008). Annu. Rev. Biophys. 37, 135–151.
Coveney, P. V. & Fowler, P. W. (2005). J. R. Soc. Interface, 2, 267–280.
Dror, R. O., Dirks, R. M., Grossman, J. P., Xu, H. F. & Shaw, D. E.
(2012). Annu. Rev. Biophys. 41, 429–452.
Ellis, R. J. (2001). Curr. Opin. Struct. Biol. 11, 114–119.
Fletcher, J. M., Harniman, R. L., Barnes, F. R. H., Boyle, A. L.,
Collins, A., Mantell, J., Sharp, T. H., Antognozzi, M., Booth, P. J.,
Linden, N., Miles, M. J., Sessions, R. B., Verkade, P. & Woolfson,
D. N. (2013). Science, 340, 595–599.
Gur, M., Zomot, E. & Bahar, I. (2013). J. Chem. Phys. 139, 121912.
Harvey, J. N. (2004). Faraday Discuss. 127, 165–177.
Humphrey, W., Dalke, A. & Schulten, K. (1996). J. Mol. Graph. 14,
33–38.
Kamp, M. W. van der & Mulholland, A. J. (2013). Biochemistry, 52,
2708–2728.
Kim, D.-N., Altschuler, J., Strong, C., McGill, G. & Bathe, M. (2011).
Nucleic Acids Res. 39, D451–D455.
Le Grand, S., Go¨tz, A. W. & Walker, R. C. (2013). Comput. Phys.
Commun. 184, 374–380.
Lindorff-Larsen, K., Piana, S., Dror, R. O. & Shaw, D. E. (2011).
Science, 334, 517–520.
Lonsdale, R., Harvey, J. N. & Mulholland, A. J. (2010). J. Phys. Chem.
Lett. 1, 3232–3237.
research papers
Acta Cryst. (2015). D71, 162–172 Gray et al.  Computational techniques for biomolecular simulation 171
Lonsdale, R., Harvey, J. N. & Mulholland, A. J. (2012a). Chem. Soc.
Rev. 41, 3025–3038.
Lonsdale, R., Harvey, J. N. & Mulholland, A. J. (2012b). J. Chem.
Theory Comput. 8, 4637–4645.
Lonsdale, R., Houghton, K. T., Z˙urek, J., Bathelt, C. M., Foloppe, N.,
de Groot, M. J., Harvey, J. N. & Mulholland, A. J. (2013). J. Am.
Chem. Soc. 135, 8001–8015.
Lonsdale, R. & Mulholland, A. J. (2014). Curr. Top. Med. Chem. 14,
1339–1347.
Lonsdale, R., Rouse, S. L., Sansom, M. S. P. & Mulholland, A. J.
(2014). PLoS Comput. Biol. 10, e1003714.
Lucˇicˇ, V., Rigort, A. & Baumeister, W. (2013). J. Cell Biol. 202,
407–419.
MacKerell, A. D., Banavali, N. & Foloppe, N. (2000). Biopolymers, 56,
257–265.
Majorek, K. A., Kuhn, M. L., Chruszcz, M., Anderson, W. F. & Minor,
W. (2014). Protein Sci. 23, 1359–1368.
Marius, P., Leung, Y. M., Piggot, T. J., Khalid, S. & Williamson, P. T. F.
(2012). Eur. Biophys. J. 41, 199–207.
Marrink, S. J., de Vries, A. H. &Mark, A. E. (2004). J. Phys. Chem. B,
108, 750–760.
Marrink, S. J. & Tieleman, D. P. (2013). Chem. Soc. Rev. 42, 6801–
6822.
McCammon, J. A., Gelin, B. R. & Karplus, M. (1977). Nature
(London), 267, 585–590.
Meyer, T., D’Abramo, M., Hospital, A., Rueda, M., Ferrer-Costa, C.,
Pe´rez, A., Carrillo, O., Camps, J., Fenollosa, C., Repchevsky, D.,
Gelpı´, J. L. & Orozco, M. (2010). Structure, 18, 1399–1409.
Noid, W. G. (2013). J. Chem. Phys. 139, 090901.
Oliver, R. C., Read, D. J., Harlen, O. G. & Harris, S. A. (2013). J.
Comput. Phys. 239, 147–165.
Orsi, M. & Essex, J. W. (2011). PLoS One, 6, e28637.
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S.,
Greenblatt, D. M., Meng, E. C. & Ferrin, T. E. (2004). J. Comput.
Chem. 25, 1605–1612.
Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa,
E., Chipot, C., Skeel, R. D., Kale´, L. & Schulten, K. (2005). J.
Comput. Chem. 26, 1781–1802.
Pronk, S., Pa´ll, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R.,
Shirts, M. R., Smith, J. C., Kasson, P. M., van der Spoel, D., Hess, B.
& Lindahl, E. (2013). Bioinformatics, 29, 845–854.
Ranaghan, K. E. &Mulholland, A. J. (2009). Int. Rev. Phys. Chem. 29,
65–133.
Richardson, R., Papachristos, K., Read, D., Harlen, O., Harrison, M.,
Paci, E., Muench, S. P. & Harris, S. A. (2014). Proteins, 82, 3298–
3311.
Rodgers, T. L., Townsend, P. D., Burnell, D., Jones, M. L., Richards,
S. A., McLeish, T. C. B., Pohl, E., Wilson, M. R. & Cann, M. J.
(2013). PLoS Biol. 11, e1001651.
Rueda, M., Ferrer-Costa, C., Meyer, T., Perez, A., Camps, J., Hospital,
A., Gelpi, J. L. & Orozco, M. (2007). Proc. Natl Acad. Sci. USA,
104, 796–801.
Scott, K. A., Bond, P. J., Ivetac, A., Chetwynd, A. P., Khalid, S. &
Sansom, M. S. P. (2008). Structure, 16, 621–630.
Shaw, D. E., Maragakis, P., Lindorff-Larsen, K., Piana, S., Dror, R. O.,
Eastwood, M. P., Bank, J. A., Jumper, J. M., Salmon, J. K., Shan,
Y. B. & Wriggers, W. (2010). Science, 330, 341–346.
Suhre, K. & Sanejouand, Y.-H. (2004). Nucleic Acids Res. 32, W610–
W614.
Tozzini, V. (2010). Q. Rev. Biophys. 43, 333–371.
Tzeng, S.-R. & Kalodimos, C. G. (2012). Nature (London), 488,
236–240.
Woods, C. J., Malaisree, M., Long, B., McIntosh-Smith, S. &
Mulholland, A. J. (2013). Biochemistry, 52, 8150–8164.
Zhao, G. P., Perilla, J. R., Yufenyuy, E. L., Meng, X., Chen, B., Ning,
J. Y., Ahn, J., Gronenborn, A. M., Schulten, K., Aiken, C. & Zhang,
P. J. (2013). Nature (London), 497, 643–646.
Zhao, H. & Schuck, P. (2015). Acta Cryst. D71, 3–
14.
Zuckerman, D. M. (2011). Annu. Rev. Biophys. 40, 41–62.
research papers
172 Gray et al.  Computational techniques for biomolecular simulation Acta Cryst. (2015). D71, 162–172
